BACKGROUND: Atrial fibrillation (AF) has been associated with myocardial oxidative stress, and antioxidant agents have demonstrated antiarrhythmic benefit in humans. We compared serum markers of oxidation and associated inflammation in individuals with or without AF. METHODS: Serum markers of oxidative stress and inflammation were compared in a cross-sectional, case-control design study of 40 male individuals, with or without persistent or permanent AF, who were matched for age, sex, diabetes, and smoking status, known confounding variables for the measurement of oxidative stress. We used derivatives of reactive oxidative metabolites (DROMs) and ratios of oxidized to reduced glutathione (E(h) GSH) and cysteine (E(h) CySH) to quantify oxidative stress. We also measured inflammatory markers, including high-sensitivity C-reactive protein, interleukins 1beta and 6, and tumor necrosis factor alpha. RESULTS: Univariate, conditional logistical regression analysis showed that oxidative stress but not inflammatory markers were statistically associated with AF (P <0.05). The increase in the odds ratios for AF for E(h) GSH, E(h) CySH, and DROMs were 6.1 (95% CI, 1.3-28.3; P = 0.02), 13.6 (95% CI, 2.5-74.1; P = 0.01), and 15.9 (95% CI, 1.7-153.9; P = 0.02), respectively. There was a stronger correlation between E(h) GSH and E(h) CySH (r = 0.66) than between E(h) GSH and DROMs (r = 0.41). In multivariate analysis corrected for statins and other AF risk factors differing between the groups, the association of AF and oxidative stress remained significant. CONCLUSIONS: These data suggest that oxidative stress markers may have predictive value in AF management.
BACKGROUND:Atrial fibrillation (AF) has been associated with myocardial oxidative stress, and antioxidant agents have demonstrated antiarrhythmic benefit in humans. We compared serum markers of oxidation and associated inflammation in individuals with or without AF. METHODS: Serum markers of oxidative stress and inflammation were compared in a cross-sectional, case-control design study of 40 male individuals, with or without persistent or permanent AF, who were matched for age, sex, diabetes, and smoking status, known confounding variables for the measurement of oxidative stress. We used derivatives of reactive oxidative metabolites (DROMs) and ratios of oxidized to reduced glutathione (E(h) GSH) and cysteine (E(h) CySH) to quantify oxidative stress. We also measured inflammatory markers, including high-sensitivity C-reactive protein, interleukins 1beta and 6, and tumor necrosis factor alpha. RESULTS: Univariate, conditional logistical regression analysis showed that oxidative stress but not inflammatory markers were statistically associated with AF (P <0.05). The increase in the odds ratios for AF for E(h) GSH, E(h) CySH, and DROMs were 6.1 (95% CI, 1.3-28.3; P = 0.02), 13.6 (95% CI, 2.5-74.1; P = 0.01), and 15.9 (95% CI, 1.7-153.9; P = 0.02), respectively. There was a stronger correlation between E(h) GSH and E(h) CySH (r = 0.66) than between E(h) GSH and DROMs (r = 0.41). In multivariate analysis corrected for statins and other AF risk factors differing between the groups, the association of AF and oxidative stress remained significant. CONCLUSIONS: These data suggest that oxidative stress markers may have predictive value in AF management.
Authors: Francisco Marín; Domingo A Pascual; Vanessa Roldán; José María Arribas; Miguel Ahumada; Pedro Luis Tornel; Clara Oliver; Jesús Gómez-Plana; Gregory Y H Lip; Mariano Valdés Journal: Am J Cardiol Date: 2005-11-07 Impact factor: 2.778
Authors: C A Carnes; M K Chung; T Nakayama; H Nakayama; R S Baliga; S Piao; A Kanderian; S Pavia; R L Hamlin; P M McCarthy; J A Bauer; D R Van Wagoner Journal: Circ Res Date: 2001-09-14 Impact factor: 17.367
Authors: Sven Wassmann; Ulrich Laufs; Kirsten Müller; Christian Konkol; Katja Ahlbory; Anselm T Bäumer; Wolfgang Linz; Michael Böhm; Georg Nickenig Journal: Arterioscler Thromb Vasc Biol Date: 2002-02-01 Impact factor: 8.311
Authors: Siobhan E Moriarty; Jheel H Shah; Michael Lynn; Shunai Jiang; Kyle Openo; Dean P Jones; Paul Sternberg Journal: Free Radic Biol Med Date: 2003-12-15 Impact factor: 7.376
Authors: Dean P Jones; Vino C Mody; Joanne L Carlson; Michael J Lynn; Paul Sternberg Journal: Free Radic Biol Med Date: 2002-11-01 Impact factor: 7.376
Authors: Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung Journal: Circulation Date: 2003-11-17 Impact factor: 29.690
Authors: Yongliang Liang; James R Roede; Sergey Dikalov; Nana Gletsu Miller; Samuel C Dudley; Arshed Quyyumi; Dean P Jones Journal: Clin Chim Acta Date: 2012-06-08 Impact factor: 3.786
Authors: Dean P Jones; Youngja Park; Nana Gletsu-Miller; Yongliang Liang; Tianwei Yu; Carolyn Jonas Accardi; Thomas R Ziegler Journal: Nutrition Date: 2010-05-14 Impact factor: 4.008
Authors: Nana Gletsu-Miller; Jason M Hansen; Dean P Jones; Young-Mi Go; William E Torres; Thomas R Ziegler; Edward Lin Journal: Obesity (Silver Spring) Date: 2008-12-11 Impact factor: 5.002